Dilemmas regarding the use of CMV-specific immunoglobulin in pregnancy

Journal of Clinical Virology

Volumn 57, Issue 2, 2013, Pages 95-97

  Evans, C ^a   Brooks, A ^b   Anumba, D ^b   Raza, M ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; INFLUENZA VACCINE;

ADULT; CASE REPORT; COMMON COLD; COUGHING; CYTOMEGALOVIRUS; EXERCISE TOLERANCE; FEMALE; HEADACHE; HUMAN; INFLUENZA; LETHARGY; MEDICAL HISTORY; NOTE; PREGNANCY; PRIORITY JOURNAL; SEROLOGY;

ADULT; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84876955118     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.12.007     Document Type: Note

References (21)

1. Dollard S.C., Staras S.A., Amin M.M., Schmid D.S., Cannon M.J. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clin Vaccine Immunol 2011, 18(November (11)):1895-1899.
2. Lazzarotto T., Spezzacatena P., Pradelli P., Abate D.A., Varani S., Landini M.P. Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. Clin Diagn Lab Immunol 1997, 4(July (4)):469-473.
3. Adler S.P. Screening for cytomegalovirus during pregnancy. Infect Dis Obstet Gynecol 2011, 2011:1-9.
4. Enders G., Daiminger A., Bader U., Exler S., Enders M. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 2011, 52(November (3)):244-246.
5. Bodeus M., Kabamba-Mukadi B., Zech F., Hubinont C., Bernard P., Goubau P. Human cytomegalovirus in utero transmission: follow-up of 524 maternal seroconversions. J Clin Virol 2010, 47(February (2)):201-202.
6. Yinon Y., Farine D., Yudin M.H. Screening, diagnosis, and management of cytomegalovirus infection in pregnancy. Obstet Gynecol Surv 2010, 65(November (11)):736-743.
7. Lazzarotto T., Varani S., Guerra B., Nicolosi A., Lanari M., Landini M.P. Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 2000, 137(July (1)):90-95.
8. Guerra B., Lazzarotto T., Quarta S., Lanari M., Bovicelli L., Nicolosi A., et al. Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2000, 183(August (2)):476-482.
9. Bonalumi S., Trapanese A., Santamaria A., D'Emidio L., Mobili L. Cytomegalovirus infection in pregnancy: review of the literature. J Prenat Med 2011, 5(January (1)):1-8.
10. Nigro G., Adler S.P., La Torre R., Best A.M., Congenital Cytomegalovirus Collaborating G. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005, 353(September (13)):1350-1362.
11. La Torre R., Nigro G., Mazzocco M., Best A.M., Adler S.P. Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin Infect Dis 2006, 43(October (8)):994-1000.
12. Buxmann H., Stackelberg O.M., Schlosser R.L., Enders G., Gonser M., Meyer-Wittkopf M., et al. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis. J Perinat Med 2012, 40(4):439-446.
13. Nigro G., Adler S.P., Parruti G., Anceschi M.M., Coclite E., Pezone I., et al. Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy - a case-control study of the outcome in children. J Infect Dis 2012, 205(January (2)):215-227.
14. Visentin S., Manara R., Milanese L., Da Roit A., Forner G., Salviato E., et al. Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. Clin Infect Dis 2012, 55(August (4)):497-503.
15. Adler S.P., Nigro G. Findings and conclusions from CMV hyperimmune globulin treatment trials. J Clin Virol 2009, 46(December (Suppl. 4)):S54-S57.
16. Forsgren M. Prevention of congenital and perinatal infections. Euro Surveill 2009, 14(March (9)):2-4.
17. Cahill A.G., Odibo A.O., Stamilio D.M., Macones G.A. Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis. Am J Obstet Gynecol 2009, 201(November (5)). 466 e1-7.
18. Griffiths P.D. Strategies to prevent CMV infection in the neonate. Semin Neonatol 2002, 7(August (4)):293-299.
19. Revello M.G., Fabbri E., Furione M., Zavattoni M., Lilleri D., Tassis B., et al. Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience. J Clin Virol 2011, 50(April (4)):303-307.
20. Vauloup-Fellous C., Picone O., Cordier A.G., Parent-du-Chatelet I., Senat M.V., Frydman R., et al. Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol 2009, 46(December (Suppl. 4)):S49-S53.
21. Johnson J., Anderson B., Pass R.F. Prevention of maternal and congenital cytomegalovirus infection. Clin Obstet Gynecol 2012, 55(June (2)):521-530.